KLK3 and prostate cancer: There is currently much interest in standardising high-quality prostate MRI, as this is of paramount importance especially when it comes to MRI-derived targeted biopsies used to detect clinically significant prostate cancer, since a patient with a negative scan and favourable prostate-specific antigen (PSA) kinetics should confidently avoid unnecessary immediate biopsy [13].